High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: A French Society of Pediatric Oncology Study

Journal of Clinical Oncology

Volumn 16, Issue 10, 1998, Pages 3295-3301

  Pein, François ^a   Michon, Jean ^a   Valteau Couanet, Dominique ^a   Quintana, Erica ^a   Frappaz, Didier ^a   Vannier, Jean Pierre ^a   Philip, Thierry ^a   Bergeron, Christophe ^a   Baranzelli, Marie Christine ^a   Thyss, Antoine ^a   Stephan, Jean Louis ^a   Boutard, Patrick ^a   Gentet, Jean Claude ^a   Zucker, Jean Michel ^a   Tournade, Marie France ^a   Hartmann, Olivier ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; MELPHALAN;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BLOOD TOXICITY; CANCER RECURRENCE; CANCER STAGING; CARDIOTOXICITY; CHILD; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL TOXICITY; HIGH RISK POPULATION; HUMAN; INFECTIOUS COMPLICATION; LIVER TOXICITY; LUNG TOXICITY; MALE; NEPHROBLASTOMA; NEPHROTOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

EID: 0031725726     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.10.3295     Document Type: Article

References (37)

1. Tournade MF, Com-Nouguè C, Voûte PA, et al: A risk adapted therapeutic approach in Wilms' tumor: Results of the SIOP 6 Wilms' tumor trial and study. J Clin Oncol 11:1014-1023, 1993
2. Tournade MF, De Kraker J, Lemerle J, et al: Pre-operative chemotherapy of patients over 6 months of age with a nephroblastoma. A report of the SIOP Wilm's tumour trials and studies. Med Pediatr Oncol 23:171, 1994 (abstr)
3. D'Angio GJ, Breslow NE, Beckwith JB, et al: Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer 64:349-360, 1989
4. Green DM, Breslow NE, Beckwith JB, et al: Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 16:237-241, 1998
5. Pritchard J, Imeson J, Cotteril S, et al: Results of the United Kingdom Children's Cancer Study Group First Wilms' Tumor Study. J Clin Oncol 13:124-133, 1995
6. Tournade MF, Lemerle J, Brunat-Mentigny M, et al: Ifosfamide is an active drug in Wilms' tumor: A phase II study conducted by the French Society of Pediatric Oncology. J Clin Oncol 6:793-796, 1988
7. Pein F, Pinkerton R, Tournade MF, et al: Etoposide in relapsed Wilms' tumor: A phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group. J Clin Oncol 11:1478-1481, 1993
8. Pein F, Tournade MF, Zucker JM, et al: Etoposide and carboplatin: A highly effective combination in relapsed or refractory Wilms' tumor - A phase II study by the French Society of Pediatric Oncology. J Clin Oncol 12:931-936, 1994
9. Jereb B, Isaac R, Tournade MF. et al: Survival of patients with metastases from Wilms tumor (SIOP 1, SIOP 2, SIOP 5). Eur Paediatr Hematol Oncol 2:71-76, 1985
10. Burgers JMV, Tournade MF, Bey P, et al: Abdominal recurrences in Wilms tumours: A report of the SIOP Wilms tumour trial and studies. Radiother Oncol 5:175-182, 1986
11. Grundy P, Breslow NE, Green DM, et al: Prognostic factors for children with recurrent Wilms' tumor: Results from the Second and Third National Wilms' Tumor Study. J Clin Oncol 7:638-647, 1989
12. Groot-Loonen JJ, Pinkerton CR, Morris-Jones PA, et al: How curable is relapsed Wilms' tumor? The United Kingdom Children's Cancer Study Group. Arch Dis Child 65:967-970, 1990
13. Pinkerton CR, Groot-Loonen JJ, Morris-Jones PH, et al: Response rates in relapses Wilms' tumor. A need for new effective agents. Cancer 67:567-571, 1991
14. Calvert AH, Newell DR, Gumbrell LA, et al: Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J Clin Oncol 7:1748-1756, 1989
15. Thomas ED, Storb R: Technique for human marrow grafting. Blood 36:507-515, 1970
16. MacDonald J, Haller D, Mayer R: Grading of toxicity, in MacDonald J, Haller D, Mayer R (eds): Manual of Oncologic Therapeutics. Philadelphia, PA, Lippincott, 1995, pp 519-523
17. Kaplan EI, Meier P: Non-parametric estimation for incomplete observation. J Am Stat Assoc 53:457-481, 1958
18. Miser JS, Tournade MF: The management of relapsed Wilms tumor. Hematol Oncol Clin North Am 9:1287-1302, 1995
19. Sutow WW, Breslow NE, Palmer NF, et al: Prognosis in children with Wilms' tumor prior to or following primary treatment. Results from the first National Wilms' Tumor Study. Am J Clin Oncol 5:339-347, 1982
20. Cushing BA, Watts FB, Brough AJ, et al: Significance of mediastinal metastatic disease in Wilms' tumor of favorable histology. Med Pediatr Oncol 12:123-126, 1984
21. Green DM, Beckwith JB, Breslow NE, et al: Treatment of children with stages II to IV anaplastic Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 12:2126-2121, 1994
22. Kung F, Hayes A, Krisher J, et al: Clinical trial of etoposide (VP-16) in children with recurrent malignant tumors. A phase II study from the Pediatric Oncology Group. Invest New Drugs 6:31-36, 1988
23. Bagnulo S, Perez DJ, Barett A, et al: High dose melphalan and autologous bone marrow transplantation for solid tumours of childhood. Eur Paediatr Haematol Oncol 2:123-133, 1985
24. Baum ES, Gaynon P, Greenberg L, et al: Phase II trial of cisplatin in refractory childhood cancers: Children's Cancer Study Group report. Cancer Treat Rep 65:815-822, 1981
25. Lewis IJ, Stevens MCG, Pearson ADJ, et al: Phase II study of carboplatin in children's tumors. Proc Am Soc Clin Oncol 12:412, 1993 (abstr 1413)
26. De Camargo B, Malarangno R, Saba e Silva N, et al: Phase II study of carboplatin as a single drug for relapsed Wilms tumor: Experience of the Brazilian Wilms Tumor Study Group. Med Pediatr Oncol 22:258-260, 1994
27. Zoubek A, Kajtar P, Fink FM, et al: Response to carboplatin (CBDCA) monotherapy in children with stage IV and relapsed Wilms' tumor. Proc Am Soc Clin Oncol 12:410, 1993 (abstr 1402)
28. Douglass EC, Wilimas JA, Sackey K, et al: Efficacy of combination cisplatin (DDP) and VP-16 in the treatment of recurrent and advanced Wilms' Tumor. Proc Am Soc Clin Oncol 5:201, 1986 (abstr 789)
29. Loh W, Ortega JA, Wolff J, et al: Cisplatinum/VP-16 for the retrieval of Wilms' tumor relapsing on chemotherapy. Proc Am Soc Clin Oncol 6:222, 1987 (abstr 876)
30. Abratt RP, Du Preez HM, Kaschula R: Adult Wilms' tumor: Cisplatin and etoposide for relapse after adjuvant chemotherapy. Cancer 65:890-892, 1990
31. Tannous R, Coccia P, Sposto B, et al: Salvage intensive/ sequential chemotherapy plus surgery for Wilms' tumor: A Children Cancer Group (CCG-4921) Study report. Proc Am Soc Clin Oncol 14:443, 1995 (abstr 1415)
32. Miser J, Krailo M, Hammond GD: The combination of ifosfamide, etoposide, and mesna: A very active regimen in the treatment of recurrent Wilms' tumor. Proc Am Soc Clin Oncol 12:417, 1993 (abstr 1432)
33. Garaventa A, Hartmann O, Bernard JL, et al: Autologous bone marrow transplantation for pediatric Wilms' tumor: The experience of the European Bone Marrow Transplantation Solid Tumor Registry. Med Pediatr Oncol 22:11-14, 1994
34. Warkentin PI, Brochstein JA, Strandjord SE, et al: High dose therapy followed by autologous stem cell rescue for recurrent Wilms' tumor. Proc Am Soc Clin Oncol 12:414, 1993 (abstr 1418)
35. Kletzel M, Morgan E, Cohn S, et al: Autologous (AU) bone marrow (BM)/peripheral blood stem cells (PBSC) rescue in children with relapsed Wilms tumor (WT). Med Pediatr Oncol 23:201, 1994 (abstr P-47)
36. Valteau-Couanet D, Vassal G, Pondarré C, et al: Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma. Bone Marrow Transplant 17:485-489, 1996
37. Hartmann O, Le Coroller AG, Biaise D, et al: Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: Hematologic recovery and costs. Ann Intern Med 126:600-607, 1997